Universität Duisburg-Essen (UDE)

University / College


Location: Duisburg, Essen, Germany (DE) DE

ISNI: 0000000121875445

ROR: https://ror.org/04mz5ra38

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Eculizumab use in neuromyelitis optica spectrum disorders: real-world evidence from Germany and Austria (2022) Ringelstein M, Asseyer S, Lindenblatt G, Fischer K, Pul R, Ozalp SH, Lohmann L, et al. Conference contribution Antidepressant Use and Its Association with 28-Day Mortality in Inpatients with SARS-CoV-2: Support for the FIASMA Model against COVID-19 (2022) Hoertel N, Sanchez-Rico M, Kornhuber J, Gulbins E, Reiersen AM, Lenze EJ, Fritz BA, et al. Journal article Numerical and experimental investigation of gas-gas diffusion and convection (2022) Lyu W, Kim S, Delgado A, Gatternig B, Troeger K, Schellin T Journal article Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial (2022) Eichinger A, Poetschger U, Glogova E, Bader P, Basu O, Beier R, Burkhardt B, et al. Journal article Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers (2022) Jansen RE, Van Der Lee SJ, Gomez-Fonseca D, De Rojas I, Dalmasso MC, Grenier-Boley B, Zettergren A, et al. Journal article Gender disparity regarding work-life balance satisfaction among German neuro-oncologists: a YoungNOA survey (2022) Kebir S, Lazaridis L, Wick W, Platten M, Tabatabai G, Combs SE, Schmidt T, et al. Journal article Siglec-G controls the severity of chronic lymphocytic leukemia (2022) Röder B, Fahnenstiel H, Seifert M, Schäfer S, Winkler T, Nitschke L Conference contribution 12-month trends in health-related quality of life after hospitalization - comparison of tumor entities (2022) Eichler M, Hornemann B, Hoenig K, Bergelt C, Faller H, Maatouk , Stein B, et al. Conference contribution Real-world clinical outcomes of pembrolizumab for advanced melanoma in the German ADOREG skin cancer registry (2022) Mohr P, Scherrer E, Alar V, Assaf C, Beissert S, Berking C, Eigentler T, et al. Conference contribution Predictors of long-term survival of stage IV melanoma patients: a multicenter DeCOG study on 539 patients from the prospective skin cancer registry ADOREG (2022) Placke JM, Mohr P, Bluhm L, Kahler K, Weichenthal M, Meier F, Garzarolli M, et al. Conference contribution